Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Cerilliant
Moodys
Baxter
UBS
Healthtrust
QuintilesIMS
Chubb
Harvard Business School

Generated: October 19, 2017

DrugPatentWatch Database Preview

Naphazoline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naphazoline hydrochloride and what is the scope of naphazoline hydrochloride freedom to operate?

Naphazoline hydrochloride
is the generic ingredient in ten branded drugs marketed by Pharmafair, Bausch And Lomb, Alcon, Novartis, Allergan, Akorn Inc, Altaire Pharms Inc, and Johnson And Johnson, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naphazoline hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: naphazoline hydrochloride

US Patents:0
Tradenames:10
Applicants:8
NDAs:12
Drug Master File Entries: see list6
Suppliers / Packagers: see list5
Bulk Api Vendors: see list43
Clinical Trials: see list2,290
Patent Applications: see list1,388
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naphazoline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon
NAPHCON FORTE
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC080229-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
NAPHCON-A
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC020226-001Jun 8, 1994OTCYesYes► Subscribe► Subscribe► Subscribe
Allergan
ALBALON
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC080248-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC202795-001Jan 24, 2013OTCNoNo► Subscribe► Subscribe► Subscribe
Novartis
VASOCON
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC080235-002Mar 24, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
OPCON
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC087506-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
OPCON-A
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC020065-001Jun 8, 1994OTCYesYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
NAFAZAIR
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC040073-001May 25, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
NAPHAZOLINE HYDROCHLORIDE
naphazoline hydrochloride
SOLUTION/DROPS;OPHTHALMIC083590-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Johnson And Johnson
VISINE-A
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC020485-001Jan 31, 1996OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Novartis
Moodys
Queensland Health
Medtronic
US Department of Justice
Daiichi Sankyo
McKinsey
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot